- £187.52bn
- £208.44bn
- $45.81bn
- 80
- 12
- 97
- 70
REG - AstraZeneca PLC - AstraZeneca to acquire Icosavax
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Discontinuation of two CRYSTALIZE evidence trials
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Truqap approved in US for HR+ breast cancer
AnnouncementREG - AstraZeneca PLC - Update on PACIFIC-2 Phase III trial for Imfinzi
AnnouncementREG - AstraZeneca PLC - Director Declaration
AnnouncementREG - AstraZeneca PLC - 9M and Q3 2023 results
AnnouncementREG - AstraZeneca PLC - Agreement with Eccogene for clinical stage GLP-1RA
AnnouncementREG - AstraZeneca PLC - Imfinzi combination improves PFS in liver cancer
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - AstraZeneca cell & gene therapy deal w/ Cellectis
AnnouncementREG - Stock Exch Notice - Admission to Trading - 30/10/2023
AnnouncementREG - Official List - Amendment Notice
AnnouncementRCS - SYSTRAN - SYSTRAN Translate Server Version 10 Unveiled
AnnouncementREG - AstraZeneca PLC - AstraZeneca settles Nexium liability litigations
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Dato-DXd improved PFS in breast cancer
Announcement